Certified by Founder Lodge
Casdin Capital, LLC
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $200,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with a
| Company | Date | Round | Raised |
|---|---|---|---|
Asimov |
January, 09 ,2023 | Series B | $200,000,000 |
IDRx |
August, 02 ,2022 | Series A | $122,000,000 |
Arzeda |
April, 04 ,2022 | Series B | $33,000,000 |
Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
Function Oncology |
April, 13 ,2023 | Series A | $28,000,000 |
Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
Asimov
IDRx
Arzeda
Flare Therapeutics
Function Oncology
Orbital Therapeutics
Septerna
Octave (US)
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)